Page 3 of 6
Which participants were included in this study?
Studies have a list of requirements for participants who can enrol (inclusion criteria)
and those who can’t (exclusion criteria). For this study, the main inclusion and
exclusion criteria are listed below.
Men and women were included in the study if they:
• Were at least 18 years old.
• Had a newly confirmed diagnosis of HIV.
• Had not received antiretroviral medicines for HIV.
Men and women were excluded from the study if they had:
• Known hepatitis B virus infection.
• Known resistance to certain medicines used to treat HIV.
• Severe liver disease or kidney disease.
• Any other disease(s) or taken any medicine(s) that the study doctor
thought would affect the results of the study.
Overall, 131 participants received at least one dose of DTG and 3TC. The study included
121 participants (92%) who were assigned male at birth and 10 participants (8%) who
were assigned female at birth. Of these, 120 participants identified as male and
11 participants identified as female. The average age was 35 years. The youngest
participant was 18 years old and the oldest participant was 63 years old.
Ten participants switched to a different antiretroviral treatment during the study. Main
and safety results are reported together for all 131 participants.
For more detailed information about the participants included in this study, see the
scientific results summary (a link to the summary is provided at the end of this
document).